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ntroduction of activated p21-activated kinase (PAK) is
sufﬁcient to release primary endothelial cells from con-
tact inhibition of growth. Conﬂuent cells display deﬁ-
cient activation of PAK and translocation of Rac to the
plasma membrane at matrix adhesions. Targeting Rac to
the plasma membrane rescues these cells from contact
inhibition. PAK’s ability to release human umbilical vein
endothelial cells from contact inhibition is blocked by an
unphosphorylatable form of its target Merlin, suggesting
that PAK promotes mitogenesis by phosphorylating, and
thus inactivating, Merlin. Merlin mutants, which are pre-
I
 
sumed to exert a dominant-negative effect, enable recruit-
ment of Rac to matrix adhesions and promote mitogene-
sis in conﬂuent cells. Small interference RNA–mediated
knockdown of Merlin exerts the same effects. Dominant-
negative Rac blocks PAK-mediated release from contact
inhibition, implying that PAK functions upstream of Rac
in this signaling pathway. These results provide a frame-
work for understanding the tumor suppressor function of
Merlin and indicate that Merlin mediates contact inhibi-
tion of growth by suppressing recruitment of Rac to ma-
trix adhesions.
 
Introduction
 
Normal cells cease to proliferate upon establishing cell–cell ad-
hesions (Dulbecco and Stoker, 1970). This contact-mediated
inhibition of growth is critical for tissue organization and con-
tributes to limiting the size of tissues and organs according to
body plan (Gottardi and Gumbiner, 2001). Loss of contact inhi-
bition enhances the ability of cancer cells to invade host tissues
and ultimately metastasize (Hanahan and Weinberg, 2000).
It is likely that the homophilic cell adhesion proteins’ cad-
herins initiate contact inhibition of growth, but the mechanisms
are not clear. The cadherins mediate assembly of adherens
junctions by associating with the actin cytoskeleton through
 
 
 
-catenin. Because 
 
 
 
-catenin also transduces proproliferative
Wnt signaling to the nucleus, the cadherins may inhibit prolifer-
ation by reducing the levels of 
 
 
 
-catenin available for Wnt sig-
naling (for review see Gottardi and Gumbiner, 2001). Other
studies suggest that cell–cell adhesion inhibits growth factor re-
ceptor signaling (Rahimi and Kazlauskas, 1999; Qian et al.,
2004) by segregating receptor tyrosine kinases (RTKs) from
their cognate ligands (Vermeer et al., 2003) or by inducing de-
phosphorylation of their cytoplasmic tail (Lampugnani et al.,
2003). In spite of these important insights, contact inhibition of
growth remains a poorly understood phenomenon.
The ezrin–radixin–moesin (ERM) protein Merlin is the
protein product of the 
 
NF-2
 
 tumor suppressor gene that is in-
activated in familiar type II neurofibromatosis, as well as in
sporadic Schwannomas, meningiomas, and mesotheliomas
(for review see Lim et al., 2000). Mouse genetics studies indi-
cate that Merlin may have a broader role in tumor invasion and
metastasis than manifested from its specific inactivation in
Schwann cells (McClatchey et al., 1998; Giovannini et al.,
2000). The biochemical function of Merlin and the mechanism
by which its loss contributes to tumorigenesis are not com-
pletely understood. It has been proposed that Merlin associates
with the cytoplasmic tail of CD44, a hyaluronic acid receptor,
to mediate contact inhibition of growth (Morrison et al., 2001).
However, genetic ablation of CD44 does not result in the loss
of contact inhibition, whereas knockout of Merlin induces this
effect, but it does cause destabilization of cadherin-dependent
adhesions (Lallemand et al., 2003). In addition, Merlin binds
to paxillin and appears to modify integrin-dependent organiza-
tion of the actin cytoskeleton in a density-dependent manner
(Fernandez-Valle et al., 2002). Finally, there is evidence that
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Merlin suppresses signaling by the small GTPase Rac (Shaw et
al., 2001). This effect has been attributed to the ability of Merlin
to interact with and to inhibit the Rac target effector p21-acti-
vated kinase (PAK; Kissil et al., 2003). On the other hand, PAK
phosphorylates the COOH terminus of Merlin and thereby inac-
tivates the growth-suppressive function of the protein (Kissil et
al., 2002; Xiao et al., 2002). Thus, there is evidence for both in-
hibition of PAK by Merlin and inhibition of Merlin by PAK. It is
not clear which of these two opposing functions is prevalent in
the cell or, if both are relevant, how they are regulated. In addi-
tion, the mechanism by which Merlin inhibits Rac signaling and
its relevance to contact inhibition are not known.
Rac is required for normal cell proliferation and migration
and plays a key role in cancer progression (Sahai and Marshall,
2002). To activate its target effectors and exert its biological
functions, Rac needs to translocate to the plasma membrane
and dissociate from Rho-GDI (Etienne-Manneville and Hall,
2002). Prior studies have provided evidence that integrin sig-
naling promotes recruitment of Rac to the membrane by induc-
ing the dissociation of Rac from Rho-GDI (del Pozo et al.,
2002) and/or tyrosine phosphorylation of CrkII (Abassi and
Vuori, 2002). In spite of these advances, our knowledge of the
signals that control recruitment of Rac and other Rho-GTPases
to the plasma membrane remains fragmentary.
We provide evidence that activation of PAK is sufficient to
release endothelial cells from contact inhibition. PAK exerts this
effect by phosphorylating, and thus inactivating, Merlin. Bio-
chemical and imaging studies indicate that dephosphorylated
Merlin suppresses recruitment of Rac to the plasma membrane in
contact-inhibited cells. These results indicate that Merlin medi-
ates contact inhibition of growth with a signaling mechanism.
 
Results
 
Mitogenic activation of Ras proceeds 
normally, but signaling to ERK is 
attenuated in contact-inhibited 
endothelial cells
 
To avoid the potential effects of immortalization on growth
control, we studied contact inhibition of growth in primary
cultures of human umbilical vein endothelial cells (HUVEC).
These cells undergo growth arrest and fail to respond to
bFGF, EGF, and insulin as they become confluent and assem-
ble vascular endothelial (VE)-cadherin–dependent junctions
(Fig. S1, A–C, available at http://www.jcb.org/cgi/content/
full/jcb.200503165/DC1). Assembly of tight junctions may
prevent diffusion of peptide growth factors from the medium
to the basolateral surface of polarized epithelial cells in vivo
(Vermeer et al., 2003). However, experiments on cells plated
on Transwell filters showed that contact inhibition of HUVEC
is not caused by a segregation of RTKs from their cognate
ligands (Fig. S1, A and C). In addition, GST pull-down assays
with the Ras-binding domain of Raf (GST-Raf-RBD) pro-
vided evidence that cell–cell contact does not interfere with
joint integrin–RTK signaling to Ras (Fig. S1 D), suggesting
that the reported effect of VE-cadherin on growth factor
receptor activation (Lampugnani et al., 2003) is not neces-
sary for contact inhibition. Interestingly, extracellular signal-
related protein kinase (ERK) was activated in a less sustained
manner in confluent cells than in sparse cells (Fig. S1 E). We
note that cell–cell contact may induce attenuation of Ras to
ERK signaling through inhibition of PAK (Fig. 1 C), as PAK
functions downstream of Ras to promote activation of ERK
(King et al., 1998). These observations indicate that cell con-
tact does not inhibit signaling to Ras but attenuates activation
of ERK in HUVEC.
 
PAK activation is sufficient to release 
endothelial cells from contact inhibition
 
To identify the mechanism by which cell–cell contact inhib-
its cell proliferation, we used a functional complementation
Figure 1. Activation of PAK is sufficient for release from contact inhibition.
(A) HUVEC were transfected with GFP alone or in combination with
plasmids encoding the indicated activated signaling molecules. G0-syn-
chronized cells were plated on FN under sparse or confluent conditions.
The percentage of transfected (GFP-positive) cells entering into S phase after
mitogen treatment was determined by anti-BrdU staining. The percentage of
sparse cells transfected with GFP alone entering in S phase ranged between
35 and 75%, depending on the experiment. This control value was normal-
ized to 100% rescue. (B) Cells transfected with GFP in combination with the
indicated doses of plasmids encoding activated PAK (PAK-CAAX) or domi-
nant-negative PAK (PAK-CAAX-KD) were synchronized in G0 and plated on
FN under either sparse or confluent conditions. The picture shows GFP-
positive (green) PAK-CAAX transfectants that have incorporated BrdU (red)
in spite of cell contact. (C) G0-synchronized cells were detached, kept in
suspension or plated on FN under sparse or confluent conditions for 4 h,
and treated with mitogens for 10 min or left untreated. Lysates were sub-
jected to immune complex kinase assay with anti-PAK using myelin basic
protein as a substrate. Error bars represent the mean   SD. 
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approach. HUVEC were transiently transfected with plas-
mids encoding GFP in combination with the activated ver-
sions of various signaling proteins. BrdU incorporation was
used to evaluate the ability of each activated signaling protein,
and certain combinations thereof, to promote proliferation of
confluent HUVEC. Notably, activated PAK (PAK-CAAX) ef-
fectively rescued progression through G1 and entry into S
phase in confluent HUVEC (Fig. 1 A), and it did so in a dose-
dependent manner (Fig. 1 B). None of the other activated
signaling proteins tested were able to exert this effect as
efficiently as activated PAK (Fig. 1 A). In particular, mem-
brane-targeted p110 (myr-p110) and Akt (myr-Akt), as well
as unphosphorylatable, stabilized 
 
 
 
-catenin (S35/37/41/45A-
 
 
 
-catenin–S4xA-
 
 
 
-catenin), did not promote entry into S phase
in contact-inhibited HUVEC, suggesting that inhibition of
phosphatidylinositol-3 kinase or 
 
 
 
-catenin does not play a
significant role in contact inhibition of growth. Activated
 
 
 
-catenin’s lack of effect is consistent with the observation
that genetic ablation of 
 
 
 
-catenin does not induce growth ar-
rest but, instead, releases HUVEC from contact inhibition
(Lampugnani et al., 2003). Similarly negative results were
obtained with activated versions of Cdc42 (Cdc42-V12) and
Rho A (Rho-L63; Fig. 1 A). By contrast, activated Rac (Rac-
L61), Raf (Raf-CAAX), and MEK (MEK-
 
 
 
N3) exerted a
partial effect (Fig. 1 A), suggesting that inhibition of Rac and
ERK may contribute to contact inhibition of growth. Control
experiments indicated that none of the constructs tested in-
duced significant apoptosis (
 
 
 
5%) in confluent HUVEC. We
note that VE-cadherin–mediated adhesion protects HUVEC
from apoptosis (Carmeliet et al., 1999). These results indi-
cate that activation of PAK is sufficient to release HUVEC
from contact inhibition.
To examine the effect of cell–cell contact on PAK acti-
vation, HUVEC were plated on fibronectin (FN) under either
sparse or confluent conditions in the presence or absence of
growth factors and subjected to PAK assay. In agreement
with prior results (del Pozo et al., 2000), adhesion to FN in-
duced strong activation of PAK in sparse cells, whereas
growth factor stimulation did not exert this effect in sus-
pended cells (Fig. 1 C), suggesting that integrin engagement
is necessary and sufficient for activation of PAK. Notably,
PAK was not activated in cells plated on FN under confluent
conditions, whether they were treated with growth factors or
not (Fig. 1 C), indicating that cell contact suppresses activa-
tion of PAK.
To examine whether PAK activation is necessary for
normal cell proliferation, we used a dominant-negative ap-
proach. As shown in Fig. 1 B, expression of a kinase-dead ver-
sion of PAK (PAK-CAAX-KD) prevented the entry into S
phase of HUVEC plated on FN under sparse conditions. These
results suggest that integrin-mediated activation of PAK is
necessary for cell cycle progression and imply that cell–cell
adhesion inhibits cell proliferation by preventing the activa-
tion of PAK.
Figure 2. Contact inhibition proceeds through suppression of
the recruitment of Rac to the plasma membrane. (A) G0-synchro-
nized HUVEC were detached and plated on FN under either
sparse or confluent conditions. 4 h later, they were stimulated
with mitogens for the indicated times and subjected to subcellular
fractionation. The cytosolic (C) and crude membrane (M) frac-
tions were isolated as described in Materials and methods. 2  g
of proteins from each fraction were analyzed by immunoblotting
with the indicated antibodies. Asterisks point to the integrin pre-
 1 subunit. (B) Cells transfected with GFP-Rac were synchronized
in G0 and plated on FN under either sparse or confluent condi-
tions. 4 h later they were treated with FN-coated beads for 25
min, fixed, and stained with DAPI (blue). Arrows point to FN-
coated beads that had induced recruitment of GFP-Rac. The
graph shows the percentage of cell-bound FN or PL beads that
had caused recruitment of Rac under the indicated conditions.
(C) G0-synchronized cells were plated on FN under sparse or
confluent conditions or kept in suspension and treated with mito-
gens for 10 min or left untreated. GTP-Rac was measured by pull-
down with GST-PAK-PBD. (D) Cells were cotransfected with GFP
and empty vector or two different doses of HA-tagged myristoy-
lated Rac (Myr-Rac) or with HA-Rac-L61. G0-synchronized cells
were plated on FN under sparse or confluent conditions and in-
cubated with mitogens and BrdU for 20 h. The percentage of
transfected cells entering S phase was determined as described
in Fig. 1 A. Expression levels were determined by immunoblotting
with anti-HA (insets). Error bars represent the mean   SD. 
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Contact inhibition proceeds through 
suppression of recruitment of Rac to the 
membrane
 
PAK is a well established target effector of Rac (Etienne-Manne-
ville and Hall, 2002). However, constitutively active Rac-
L61 did not fully rescue cell cycle progression in confluent
HUVEC, whereas activated PAK did (Fig. 1 A). We consid-
ered the possibility that Rac-L61 did not exert a proprolifera-
tive effect in confluent cells because of incorrect targeting. To
examine whether cell–cell contact interferes with the recruit-
ment of Rac to the plasma membrane, we used biochemical
fractionation and optical imaging methods. HUVEC were
plated on FN under either sparse or confluent conditions for 4 h
and treated with growth factors. At various times after mito-
genic stimulation the cells were subjected to biochemical frac-
tionation and immunoblotting. As shown in Fig. 2 A, the crude
membrane fraction of cells plated on FN under sparse condi-
tions contained a significant amount of Rac (
 
 
 
25% of the to-
tal). Mitogenic stimulation did not modify the proportion of
Rac in the crude membrane fraction of these cells. These obser-
vations are in agreement with the model that RTKs induce
GTP-loading on Rac, whereas integrins mediate its recruitment
to the membrane and coupling to target effectors (del Pozo et
al., 2000, 2002). Parenthetically, prolonged mitogenic stimula-
tion led to increased levels of Rac in both the cytosolic and the
crude membrane fraction of sparse cells, suggesting that Rac
levels increase in mid-to-late G1 in HUVEC. Interestingly,
most of the total Rac (
 
 
 
95%) remained in the cytosolic frac-
tion in confluent cells, indicating that the translocation of Rac
to the membrane fraction is impaired in confluent cells (Fig. 2 A).
This result indicates that cell contact suppresses recruitment of
Rac to the plasma membrane.
To confirm and extend this result, we used optical imag-
ing. HUVEC were transiently transfected with GFP fused to
wild-type Rac under conditions inducing low levels of expres-
sion (
 
 
 
10-fold lower than endogenous Rac by immunoblot-
ting), plated on FN under sparse or confluent conditions, and
imaged by confocal microscopy. As expected, GFP-Rac local-
ized to lamellipodia and membrane ruffles in sparse cells.
Analysis of Z-sections indicated that most of the protein asso-
ciated with the ventral membrane in these cells. By contrast,
GFP-Rac appeared predominantly distributed throughout the
cytoplasm in confluent cells (unpublished data). To obtain
more quantitative data and to determine if, and to what extent,
cell contact specifically suppresses the recruitment of Rac to
matrix adhesions, we applied FN- or control poly-
 
L
 
-lysine
(PL)–coated beads to sparse or confluent HUVEC. As shown
in Fig. 2 B, the FN-coated beads caused efficient recruitment of
GFP-Rac in sparse cells, but they did not exert this effect in
confluent cells. The PL beads promoted negligible recruitment
of Rac in sparse cells, as anticipated. These results indicate that
cell–cell contact suppresses integrin-dependent recruitment of
Rac to the plasma membrane.
To examine the effect of cell contact on activation of Rac,
we conducted pull-down experiments with GST-PAK. We ob-
served that cell contact inhibits growth factor–induced activa-
tion of Rac only partially, whereas loss of matrix adhesion
suppresses this event to a significant extent (Fig. 2 C). Al-
though we cannot exclude other mechanisms, we posit that the
partial decrease of GTP loading on Rac observed in confluent
cells is a consequence of reduced recruitment to the plasma
membrane, and hence activation, of Rac by RTKs. Prior studies
have shown that a fraction of Rac is activated transiently dur-
ing the formation of cell–cell junctions (Ehrlich et al., 2002).
We believe it is unlikely that this local and transient activation
of Rac influenced the outcome of our experiment because the
cells were plated under confluent conditions for 4 h before
growth factor treatment and GST pull-down assay, and control
experiments had indicated that this time is sufficient for assem-
bly of cell–cell junctions. These results are consistent with the
hypothesis that cell contact inhibits Rac signaling predomi-
nantly by inhibiting localization of Rac to the membrane.
Rac signaling promotes progression through G1 in HUVEC
(Mettouchi et al., 2001) and several other cell types (Etienne-
Manneville and Hall, 2002). If Rac needs to associate with the
plasma membrane to be properly coupled to its target effectors,
inhibition of this process may underlie contact inhibition. To ex-
amine this hypothesis, we tested whether targeting wild-type Rac
to the membrane was sufficient to release HUVEC from contact
inhibition. Cells were transfected with Myr-Rac, which carries a
Src myristoylation site at its NH
 
2
 
 terminus, but no additional
mutations. BrdU incorporation indicated that this membrane-
targeted form of Rac rescues a large fraction of HUVEC from
contact  inhibition whereas Rac-L61 was much less effective
(Fig. 2 D). Because Myr-Rac does not carry mutations reducing
its GTPase activity, its ability to promote proliferation of conflu-
ent HUVEC indicates that targeting Rac to the plasma membrane
is sufficient to release cells from contact inhibition of growth.
Together, these observations imply that contact inhibition of
growth involves the inhibition of membrane recruitment of Rac.
 
Activated PAK releases HUVEC from 
contact inhibition through the 
phosphorylation of Merlin
 
The aforementioned results suggest that contact inhibition pro-
ceeds through the suppression of membrane recruitment of Rac
and the inactivation of PAK, but they do not explain why inhi-
bition of PAK causes growth arrest. To address this question,
we sought to identify the target effector through which PAK re-
leases HUVEC from contact inhibition. We focused on the
PAK substrate Merlin because it is a tumor suppressor protein
and its growth-suppressing activity is regulated by phosphory-
lation (Bretscher et al., 2002). In contrast, the other known
target effectors of PAK (with the exception of Raf; see poor
rescue by activated Raf in Fig. 1 A) regulate the actin cytoskel-
eton (Bokoch, 2003).
PAK phosphorylates Merlin at Serine 518, disrupting the
interaction between the NH
 
2
 
-terminal protein 4.1 ERM domain
and the COOH-terminal tail of the protein (Shaw et al., 2001;
Kissil et al., 2002; Xiao et al., 2002). To examine the potential
role of PAK’s phosphorylation of Merlin in release from contact
inhibition, HUVEC were transfected with HA-tagged Merlin in
combination with empty vector, activated PAK (PAK-CAAX),
or dominant-negative PAK (PAK-CAAX-KD) and were plated 
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under either sparse or confluent conditions in the presence of
growth factors. High resolution SDS-PAGE followed by im-
munoblotting with anti-HA was used to monitor the mobility
shift caused by the phosphorylation of Merlin (Shaw et al.,
2001). Control transfectants plated under confluent conditions
contained more dephosphorylated Merlin as compared with
those plated under sparse conditions (Fig. 3 A). In addition, ac-
tivated PAK induced significant phosphorylation of Merlin in
confluent cells, whereas dominant-negative PAK caused an al-
most complete dephosphorylation of the protein in sparse cells
(Fig. 3 A). Immunoblotting with an antibody that specifically
recognizes Merlin phosphorylated at Serine 518 showed that
Merlin is significantly phosphorylated at this site in cells
plated under sparse conditions, but not in those plated under
confluent conditions (Fig. 3 B). In addition, activated PAK
caused significant phosphorylation of Merlin at Serine 518 in
confluent and in suspended cells, whereas kinase-dead PAK
did not exert this effect (Fig. 3 B). These results identify a po-
tential role for Merlin phosphorylation at Serine 518 in exit
from contact inhibition.
Overexpression of mutant forms of Merlin that are pre-
sumed to disrupt head-to-tail association of the protein causes
hyperproliferation in the fly wing (LaJeunesse et al., 1998) and
transforms rodent fibroblasts (Johnson et al., 2002). It has been
argued that these mutants exert a dominant-negative effect on the
growth-suppressive function of endogenous wild-type protein
(Bretscher et al., 2002). To examine if PAK controls membrane
recruitment of Rac through Merlin, we used two such mutants:
Merlin-
 
 
 
BB, which carries a deletion of the Blue Box, which is
a short amino acid segment in the protein 4.1 ERM domain
thought to be involved in head-to-tail association (LaJeunesse et
al., 1998); and Merlin-S518D, which carries a serine to aspartic
acid permutation at the PAK phosphorylation site and thus mim-
ics the phosphorylated form of Merlin (Johnson et al., 2002).
HUVEC were transfected with vector alone or HA-
tagged forms of wild-type Merlin, Merlin-
 
 
 
BB, Merlin-
S518D, and Merlin-S518A (which cannot be phosphorylated
by PAK) and plated under confluent conditions in the presence
of growth factors. BrdU incorporation experiments indicated
that Merlin-
 
 
 
BB and Merlin-S518D induce a significant frac-
tion of confluent HUVEC to progress through G1 and enter
into S phase (Fig. 3 C). By contrast, wild-type Merlin and Mer-
lin-S518A did not exert this effect. It is likely that Merlin-
 
 
 
BB
and Merlin-S510D rescue HUVEC from contact inhibition by
exerting a dominant-negative effect on the growth-suppressive
function of endogenous wild-type protein. In addition, or in-
stead, these mutants may directly stimulate cell proliferation.
These findings are consistent with the hypothesis that phos-
phorylation of Merlin mediates exit from contact inhibition.
We next used BrdU incorporation to examine the ability
of Merlin-S518A to interfere with PAK’s ability to rescue HU-
VEC from contact inhibition. HUVEC were transfected with ac-
tivated PAK in combination with HA-tagged Merlin-S518A or,
as controls, HA-tagged Merlin-WT, HA-tagged Merlin-S518D,
or vector alone. As shown in Fig. 3 D, Merlin-S518A inhibited
PAK’s ability to rescue cell proliferation in confluent HUVEC,
whereas wild-type Merlin did not exert this effect, and Merlin-
S518D enhanced the proproliferative effect of activated PAK.
These findings imply that PAK releases HUVEC from contact
inhibition of growth through phosphorylation of Merlin.
 
Merlin mediates contact inhibition 
by suppressing membrane recruitment 
of Rac
 
Previous studies have suggested that the “closed,” dephosphor-
ylated form of Merlin suppresses Rac signaling (Shaw et al.,
2001; Kissil et al., 2002), raising the possibility that PAK func-
Figure 3. PAK releases cells from contact inhibition by phosphorylating
Merlin. (A) HUVEC were transfected with HA-tagged Merlin in combina-
tion with empty vector or plasmids encoding PAK-CAAX or Pak-CAAX-KD.
G0-synchronized cells were plated on FN under sparse (Sp.) or confluent
(Co.) conditions. After incubation with growth factors for 20 h, the cells
were lysed and subjected to high resolution SDS-PAGE followed by immu-
noblotting with anti-Merlin. The top band corresponds to the phosphory-
lated form of Merlin and the bottom band to the unphosphorylated form.
(B) Total lysates prepared as in A were subjected to standard SDS-PAGE
and immunoblotting with anti–phospho-Merlin (Ser518) or anti-Merlin. (C)
Cells were cotransfected with GFP and empty vector or vectors encoding
the indicated forms of Merlin. G0-synchronized cells were plated on FN
under confluent conditions and incubated with mitogens and BrdU for 20 h.
The percentage of transfected cells entering S phase was determined as
described in Fig. 1. (D) Cells were cotransfected with GFP and empty vec-
tor or vectors encoding activated PAK (PAK-CAAX) in combination with
the indicated forms of Merlin. The percentage of transfected cells entering
S phase was determined as in Fig. 1. PAK-CAAX and various forms of
Merlin were tagged with HA and detected by immunoblotting with anti-HA
antibody. Error bar represents the mean   SD. 
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tions upstream of Rac during release from contact inhibition.
We thus examined if Merlin suppresses recruitment of Rac to
matrix adhesions in confluent cells. HUVEC were transfected
with GFP-Rac, alone or in combination with HA-tagged Mer-
lin-S518D, Merlin-
 
 
 
BB, Merlin-WT, Merlin-S518A, or empty
vector. The cells were plated under confluent conditions and
incubated with FN-coated beads. Confocal microscopy indi-
cated that expression of Merlin-
 
 
 
BB or Merlin-S518D restores
recruitment of GFP-Rac to FN-coated beads in confluent
HUVEC (Fig. 4 A). Notably, anti-HA staining indicated that
both mutant forms of Merlin localize underneath FN-coated
beads (Fig. 4 A and not depicted), in agreement with the hy-
pothesis that they interfere with the ability of endogenous Mer-
lin to suppress integrin-mediated recruitment of Rac. These
observations are consistent with the hypothesis that Merlin
suppresses recruitment of Rac to matrix adhesions in contact-
inhibited cells.
Cre-mediated deletion of Merlin causes a disruption of
cell–cell junctions in mouse embryonic fibroblasts and kerati-
nocytes, suggesting the possibility that Merlin mediates its
growth-suppressive function by stabilizing cadherin-dependent
adhesion and, thereby, inducing inhibitory cadherin signaling
(Lallemand et al., 2003). However, immunofluorescent stain-
ing with anti–
 
 
 
-catenin provided evidence that Merlin-S518D
does not cause a significant disruption of adherens junctions
under our experimental conditions (Fig. 4 B), suggesting that
Merlin uses a direct signaling mechanism to mediate contact
inhibition in HUVEC. Both Merlin-S518 and Merlin-S518A
localized in part to the inner aspect of the plasma membrane
and in part to the cytoplasm in these experiments (Fig. 4 B).
Together, the results of these experiments suggest that Merlin
mediates contact inhibition of growth by suppressing recruit-
ment of Rac to matrix adhesions.
 
siRNA-mediated knockdown of Merlin 
promotes recruitment of Rac to matrix 
adhesions and releases cells from 
contact inhibition
 
The aforementioned experiments are consistent with the model
that the dephosphorylated, closed form of Merlin suppresses
recruitment of Rac to the membrane, but they do not exclude
the possibility that the phosphorylated, “open” form of Merlin
exerts an independent and positive effect on cell proliferation.
To directly test if Merlin mediates contact inhibition of growth
by suppressing recruitment of Rac to matrix adhesions, we
used RNA interference. Transfection of a small interference
RNA (siRNA) targeting human Merlin was sufficient to rescue
integrin-dependent recruitment of GFP-Rac to the plasma
membrane in confluent HUVEC (Fig. 5 A). Notably, knock-
down of Merlin induced a large fraction of confluent HUVEC
to progress through G1 and enter into S phase after mitogenic
stimulation (Fig. 5 B). Immunoblotting revealed that the
siRNA inhibited Merlin expression by 
 
 
 
80%. As expected, the
Merlin knockdown cells escaping contact inhibition had ele-
vated levels of cyclin D1 and decreased levels of p27 (Fig. 5 B).
However, cyclin D1 was not up-regulated and p27 was not
down-regulated as effectively as they normally are in sparse
cells. We attribute this partial result to the incomplete suppres-
sion of Merlin expression after siRNA transfection.
To control for potential off-target effects of the siRNA or
activation of the interferon response, we used a rescue ap-
proach. The HUVEC were transfected with a cDNA encoding
mouse Merlin that is insensitive to the siRNA we used to in-
hibit human Merlin and were subjected to RNA interference.
As shown in Fig. 5 C, BrdU incorporation and immunoblotting
with anti–cyclin D1 and anti-p27 indicated that reexpression of
Merlin restores contact inhibition of growth in Merlin knock-
down HUVEC. These results provide evidence that Merlin is
necessary and sufficient to block membrane recruitment of Rac
Figure 4. Open forms of Merlin promote recruitment of Rac to matrix
adhesions. (A) HUVEC were transfected with GFP-Rac in combination with
empty vector or vectors encoding HA-tagged Merlin-S518D, Merlin- BB
(BB), Merlin-WT, and Merlin-S518A. FN-coated beads were applied for
25 min to G0-synchronized cells plated on FN under confluent conditions.
The cells were then fixed and stained with anti-HA to detect HA-Merlin (red)
and DAPI (blue). The graph shows the percentage of GFP-Rac–positive
beads under the indicated conditions. Arrows point to FN-coated beads
that had induced recruitment of GFP-Rac. (B) Cells were transfected with
vectors encoding HA-tagged Merlin-S518D or Merlin-S518A. G0-synchro-
nized cells were plated on FN under confluent conditions and subjected to
double staining with antibodies to  -catenin (red) and HA (green). The inset
shows that Merlin-S518D localizes in part to adherens junctions, but does
not disrupt them. Error bar represents the mean   SD. 
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and to mediate contact inhibition of growth, in agreement with
the hypothesis that the dephosphorylated closed form of Merlin
suppresses cell proliferation, whereas the phosphorylated open
form does not exert this effect.
To examine if suppression of Merlin causes disruption of
cell–cell adhesion in HUVEC, cells treated with Merlin or con-
trol siRNA were plated under confluent conditions and sub-
jected to double immunofluorescent staining with anti–VE-
cadherin and anti–
 
 
 
-catenin antibodies. As shown in Fig. 5 D,
transient inhibition of Merlin expression did not have an obvious
deleterious effect on cell–cell junctions. These observations sup-
port the hypothesis that Merlin controls cell proliferation by a
direct signaling mechanism.
Finally, we wanted to obtain additional evidence that sup-
pression of Merlin enhances Rac signaling in HUVEC. After
transfection of Merlin or control siRNA, HUVEC were plated
under sparse conditions to facilitate detection of Rac-depen-
dent structures, such as lamellipodia and ruffles, and subjected
to double immunofluorescent staining with anti-paxillin antibod-
ies and phalloidin. As shown in Fig. S2 (available at http://
www.jcb.org/cgi/content/full/jcb.200503165/DC1), suppression
of Merlin expression caused a significant loss of focal adhesions
and stress fibers in HUVEC. Concomitantly, the cells formed
extensive lamellipodia and ruffles. These observations suggest
that loss of Merlin enhances Rac signaling in HUVEC.
 
PAK controls recruitment of Rac to 
matrix adhesions
 
PAK is a key target effector of Rac, but it can also function up-
stream of Rac (Bokoch, 2003), raising the possibility that PAK
functions in proliferative signaling through Rac-mediated acti-
vation of target effectors other than PAK. This data supports
the hypothesis that PAK regulates Rac translocation to the
membrane through phosphorylation and inactivation of Merlin.
To confirm that PAK functions upstream of Rac during release
from contact inhibition, we first tested if PAK rescues cells
from contact inhibition through Rac. HUVEC were transfected
with activated PAK, alone or in combination with dominant-
negative Rac. As shown in Fig. 6 A, dominant-negative Rac
Figure 5. Merlin mediates contact inhibition of growth by suppressing
membrane recruitment of Rac. (A) HUVEC were electroporated with GFP-
Rac and then either transfected with a siRNA oligonucleotide targeting
human Merlin or mock-transfected as a control. 36 h later, cells were
synchronized in G0, detached, and plated on FN under either sparse or
confluent conditions, as indicated, and treated with FN beads. The graph
shows the percentage of GFP-Rac–positive beads under the indicated con-
ditions. (B) Cells were transfected with a siRNA oligonucleotide targeting
human Merlin ( ). G0-synchronized cells were detached, plated on FN
under sparse or confluent conditions, and incubated with mitogens and
BrdU for 20 h. The graph shows the percentage of cells entering S phase
under the indicated conditions. Total lysates were subjected to immuno-
blotting with the indicated antibodies. (C) Cells were electroporated with
a vector encoding Myc-tagged mouse Merlin (mMerlin) or empty vector
and transfected with the anti–human siRNA oligonucleotide. After 36 h,
cells were synchronized in G0, detached, and plated on FN under conflu-
ent conditions for 4 h. The cells were either incubated with mitogens and
BrdU for 20 h to measure entry into S phase or treated with mitogens for
12 h and subjected to immunoblotting with the indicated antibodies. (D)
siRNA-transfected cells were detached and plated on FN-coated coverslips
under confluent conditions in the presence of growth factors. After 20 h,
they were subjected to double immunofluorescent staining with anti–VE-
cadherin (green) and anti– -catenin (red). The bottom panels are XZ
section views of VE-cadherin and DAPI staining. Error bars represent the
mean   SD.
Figure 6. PAK promotes recruitment of Rac to matrix adhesions. (A) Cells
were cotransfected with GFP and empty vector, or vector encoding acti-
vated PAK (PAK-CAAX) or Pak-CAAX-H83/86L, in combination or not
with dominant-negative Rac (Rac-N17). G0-synchronized cells were
plated on FN under confluent conditions and incubated with mitogens and
BrdU for 20 h. The percentage of transfected cells entering S phase was
determined as described in Fig. 2. PAK-CAAX was tagged with HA and
hence detected by immunoblotting with anti-HA, whereas Rac-N17 was
tagged with Myc and thus detected with anti-Myc. (B) HUVEC were trans-
fected with GFP-Rac in combination with empty vector or vector encoding
activated PAK (PAK-CAAX). They were then synchronized in G0 and
plated on FN under sparse or confluent conditions. FN-coated beads were
applied for 25 min. The cells were fixed and stained with anti-HA to detect
PAK-CAAX (red) and DAPI to stain nuclei (blue). Arrows point to FN-
coated beads that induced recruitment of GFP-Rac. The graph shows the
percentage of GFP-Rac–positive beads under the indicated conditions.
Error bars represent the mean   SD. 
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(Rac-N17) suppressed PAK’s ability to release confluent
HUVEC from contact inhibition, suggesting that PAK functions
upstream of Rac in this process. A mutation crippling the CRIB
domain (H83/86L) did not impair the ability of activated PAK
to rescue HUVEC from contact inhibition, indicating that this
effect does not require Rac binding to PAK. As expected, domi-
nant-negative Rac also interfered with the ability of the CRIB
domain mutant form of activated PAK to release cells from con-
tact inhibition (Fig. 6 A). These findings indicate that PAK
functions upstream of Rac in release from contact inhibition.
We examined if activated PAK rescues recruitment of Rac
to integrin-dependent adhesions in confluent cells. HUVEC
were transfected with GFP-Rac, alone or in combination with
activated PAK, plated under confluent conditions, and treated
with FN-coated beads. Fig. 6 B shows that activated PAK pro-
motes recruitment of Rac to FN-coated beads in confluent
cells. Interestingly, activated PAK accumulated underneath
FN-coated beads in “rescued” cells, which is in agreement with
the hypothesis that it promotes cell proliferation by inducing
recruitment of Rac to matrix adhesions (Fig. 7 B). These obser-
vations indicate that PAK controls recruitment of Rac to matrix
adhesions by a signaling mechanism and imply that intercellu-
lar contact interferes with this process.
 
Discussion
 
Rac promotes normal cell proliferation and cancer invasion
(Sahai and Marshall, 2002). To exert its functions, Rac needs to
dissociate from Rho-GDI and attach to the inner aspect of the
plasma membrane. Our study provides evidence that the tumor
suppressor Merlin mediates contact inhibition of growth by
blocking recruitment of Rac to matrix adhesions. Upon activa-
tion, PAK reverses this inhibition by phosphorylating, and thus
inactivating, Merlin. These results place Merlin at the center
of a novel tumor suppressor–oncogene circuit and provide a
framework to interpret its function in tumorigenesis.
We have observed that PAK signaling is sufficient to re-
lease endothelial cells from contact inhibition. By contrast, ac-
tivation of other mitogenic signaling pathways, including those
involving 
 
 
 
-catenin, phosphatidylinositol-3 kinase, and ERK,
does not exert this effect. Upon introduction in sparse cells,
dominant-negative PAK promotes growth arrest, suggesting
that PAK kinase activity is required for normal cell cycle pro-
gression. Activated PAK promotes recruitment of Rac to ma-
trix adhesions in confluent cells, whereas dominant-negative
Rac blocks PAK’s ability to release cells from contact inhibi-
tion, indicating that PAK promotes mitogenesis by inducing re-
cruitment of Rac to matrix adhesions. Two distinct mutant
forms of Merlin, Merlin-
 
 
 
BB and Merlin-S518D, which are
presumed to exert a dominant-negative effect, promote recruit-
ment of Rac to matrix adhesions and release cells from contact
inhibition. By contrast, an unphosphorylatable form of Merlin,
Merlin-S518A, suppresses PAK’s ability to release HUVEC
from contact inhibition. These observations indicate that PAK
promotes recruitment of Rac to matrix adhesions and mitogen-
esis by phosphorylating and thereby inactivating Merlin.
Several lines of evidence indicate that Merlin’s ability to
suppress Rac function is necessary and sufficient for contact
inhibition of primary endothelial cells. Constitutively active
PAK, dominant-negative Merlin, and membrane-targeted Rac
are each sufficient to release HUVEC from contact inhibition.
Conversely, dominant-negative PAK promotes growth arrest
when introduced in cells that are not contact inhibited. In addi-
tion, siRNA-mediated knockdown of Merlin is sufficient to
promote recruitment of Rac to matrix adhesions and mitogene-
sis of confluent HUVEC, excluding the possibility that the
open form of Merlin directly promotes recruitment of Rac to
the membrane and mitogenesis. Thus, our results support the
hypothesis that the closed, dephosphorylated form of Merlin
inhibits proliferation and mediates contact inhibition by sup-
pressing activation of Rac, whereas the open, phosphorylated
form does not exert this effect. In addition, our results suggest
that the open, phosphorylated form may inhibit the growth-sup-
pressive function of the closed, dephosphorylated form. Future
studies will be required to elucidate the molecular basis of this
effect. Finally, we cannot exclude the possibility that the open
form of Merlin has additional functions, as it has been reported
that Merlin-S518D enhances filopodia formation in rat Schwan-
noma cells (Surace et al., 2004).
Under growth-permissive conditions, joint integrin-RTK
signaling causes recruitment and activation of Rac and, thus,
of PAK. We propose that, upon phosphorylation by PAK,
Merlin loses its ability to inhibit recruitment of Rac to the
membrane, thus facilitating Rac–PAK signaling. This positive
feed-forward mechanism of signal amplification would cause
robust activation of Rac. Finally, activated Rac would promote
cell proliferation through target effectors that were distinct
from PAK. We speculate that, upon cell–cell contact cadherin
signaling suppresses activation of PAK, leading to the accu-
mulation of unphosphorylated Merlin. This form of Merlin
would finally block proliferation by suppressing recruitment
of Rac to the membrane (Fig. 7). Several aspects of this model
require further experimental examination. Specifically, it will
be important to address the mechanism by which cadherin-
dependent adhesion suppresses PAK and the mechanism by
which Merlin inhibits recruitment of Rac to the membrane. In
Figure 7. Hypothetical model of Merlin’s function. Cadherin-initiated
adhesion prevents activation of Pak in contact-inhibited cells and thereby
causes accumulation of dephosphorylated Merlin. This closed form of
Merlin suppresses integrin-mediated recruitment of Rac, and hence mito-
genic signaling. Upon release from contact inhibition, Pak phosphorylates
and inactivates Merlin, allowing recruitment of Rac to the membrane and
mitogenic signaling. 
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addition, future studies will have to examine whether the
growth-suppressive pathway identified here also operates in
other normal cell types.
Merlin’s function as a tumor suppressor has been inves-
tigated intensively. Merlin
 
 
 
/
 
 
 
 fibroblasts and keratinocytes
display defective cadherin-dependent junctions and do not un-
dergo growth arrest upon becoming confluent (Lallemand et
al., 2003), suggesting that Merlin exerts its tumor suppressor
function by stabilizing cell–cell junctions. In this model, Mer-
lin functions upstream of cadherins, either by facilitating their
assembly or by preventing their disassembly, and it thus in-
hibits proliferative signaling indirectly. In contrast, we have
observed that dominant-negative or siRNA-mediated inhibi-
tion of Merlin rescues HUVEC from contact inhibition of
growth without disrupting cell–cell junctions. We attribute
this apparent discrepancy to the use of different methods of
inhibiting Merlin function and/or different cell types. The ef-
fect of genetic ablation is permanent and complete, whereas
the effect of dominant-negative inhibition or siRNA-mediated
knockdown is transient and often incomplete. In addition, it is
known that Rac signaling participates in both the assembly
and the disassembly of cell–cell junctions, and the extent to
which it promotes these contrasting functions may vary with
cell type (Braga, 2002). It is thus possible, and indeed likely,
that genetic ablation of Merlin causes a more robust up-regu-
lation of Rac signaling than dominant-negative or siRNA-
mediated inhibition. In addition, fibroblasts and keratinocytes
may be more sensitive to the effect of loss of Merlin function
on cell–cell junctions than endothelial cells. Regardless of
what specific mechanism explains this apparent discrepancy,
our results indicate that inhibition of Merlin can rescue cells
from contact inhibition without disrupting their junctions,
supporting the hypothesis that Merlin regulates proliferation
by a direct signaling mechanism. Similarly, studies in 
 
Dro-
sophila Melanogaster 
 
support the notion that the ERM protein
Moesin promotes epithelial organization by inhibiting Rho
signaling rather than by functioning as a cytoskeletal linker
(Speck et al., 2003).
The biochemical function of Merlin is poorly understood.
Merlin interacts with the integrin signaling component paxillin
(Fernandez-Valle et al., 2002) that functions, together with
PKL, as a scaffold to recruit PAK and PIX, a GEF for Rac, to
focal complexes (Turner, 2000). Hence, Merlin may inhibit
recruitment of Rac by the paxillin–PKL–PIX complex until it
becomes phosphorylated and thus inactivated by PAK. In ad-
dition, PAK phosphorylates Rho-GDI at Ser 101/174, promot-
ing its dissociation from Rac (DerMardirossian et al., 2004).
Although this mechanism can contribute to the recruitment of
Rac to matrix adhesions, our results clearly show that PAK
functions in this process also by phosphorylating Merlin. Mer-
lin has been shown to bind to Rho-GDI in vitro (Maeda et al.,
1999), raising the possibility that Merlin stabilizes the associa-
tion of Rac with Rho-GDI. However, we have failed to detect
association of endogenous Merlin and Rho-GDI in endothelial
cells by coimmunoprecipitation (unpublished data). Finally, re-
cent studies suggest that integrins control recruitment of Rac to
the membrane by organizing cholesterol-rich membrane micro-
domains (del Pozo et al., 2004), and dephosphorylated Merlin
tends to accumulate in these microdomains (Stickney et al.,
2004), suggesting the possibility that Merlin inhibits recruit-
ment of Rac to these membrane domains.
Rho family GTPases promote cell proliferation and mi-
gration, and they mediate Ras transformation in vitro. How-
ever, unlike Ras proteins Rho GTPases do not acquire muta-
tions that impair their GTPase activity and cause constitutive
activation in human cancer (Sahai and Marshall, 2002). It is
possible that these mutations are not sufficient to cause trans-
formation because they do not overcome the barrier imposed
by cytoplasmic segregation. PAK1 is amplified in some ovar-
ian and breast cancers (Bekri et al., 1997; Schram et al., 2003).
In addition, elevated levels of PAK1 have been detected in
breast and colorectal cancer (Balasenthil et al., 2004; Carter et
al., 2004). Finally, PAK4 is overexpressed in various carci-
noma lines (Callow et al., 2002). Based on our results, we
speculate that PAK may promote tumorigenesis by function-
ally inactivating Merlin and elevating Rac signaling.
 
Materials and methods
 
Cell culture and materials
 
HUVEC were obtained from Clonetics. Cells were synchronized in G0 by
growth factor deprivation, detached, and replated on dishes or coverslips
coated with 15 
 
 
 
g/ml of human plasma FN (BD Biosciences) at 2.5 
 
 
 
10
 
4
 
 per cm
 
2
 
 (sparse) or 1.5 
 
 
 
 10
 
5
 
 per cm
 
2
 
 (confluent). After incubation in
serum-free medium (SFM; GIBCO BRL) for 4 h, the cells were stimulated
with growth factors (20 ng/ml bFGF, 1 
 
 
 
g/ml heparin, 10 ng/ml EGF,
10 
 
 
 
g/ml insulin, 10 
 
 
 
g/ml transferrin, and 1 
 
 
 
g/ml selenous acid) for
the times indicated in the figure legends. For some experiments, the cells
were cultured on FN-coated polycarbonate filters (0.4-
 
 
 
m pore size; Trans-
well Costar). The following antibodies were purchased: anti-Rac1 (Upstate
Biotechnology); anti-RhoGDI, anti–cyclin D1 (A-12), anti-p27 (C-19), anti-
Erk2 (C-14), anti-PAK (N-20), and anti-Merlin (A-19, C-18; Santa Cruz
Biotechnology, Inc.); anti–
 
 
 
-actin (Sigma-Aldrich); anti–phospho-ERK (Cell
Signaling); anti-Ras and anti–VE-cadherin (BD Biosciences); and anti-HA
(Babco). Rabbit antibodies to 
 
 
 
-catenin and to phosphorylated Ser518
in Merlin were described previously (McCrea et al., 1993; Kissil et al.,
2002).
 
Expression vectors
 
We used expression vectors encoding wild-type and mutant forms of
Rac1 (pcDNA3 Rac-L61, Rac-N17, Myr-Rac [a gift from M. del Pozo,
Centro Nacional Investigaciones Cardiovasculares, Madrid, Spain],
pEGFP-Rac [Rac1 was subcloned into pEGFP vector {CLONTECH Labora-
tories, Inc.}], and pXJ40-HA-Rac), Cdc42 (pZip Cdc42-V12), RhoA
(pcDNA3 RhoA-L63), p110-PI3K (pCG-myr-p110), MEK1 (pMCL-MEK1-
 
 
 
N3, S222D), Raf (pZip-RafCAAX), Sos (pcDNA3 Myr-Sos1), PAK
(pXJ40-PakCAAX), Akt (pCMV-Myr-Akt), 
 
 
 
-catenin (a gift from C. Got-
tardi, Northwestern University, Chicago, IL; pCS1-HA-S35/37/41/45A-
 
 
 
-catenin or HA-S4xA-
 
 
 
-catenin), and Merlin (pXJ40-HA-MerlinI; full-
length Merlin was subcloned from pBluescript II-MerlinI [obtained from S.
Tsukita, Kyoto University, Kyoto, Japan]). The rest of the constructs were
previously described (Mettouchi et al., 2001). The Merlin I mutants
S518D, S518A, and 
 
 
 
BB (deletion of amino acid residues 177–183)
and PAK mutants PAK-CAAX-K298R and PAK-CAAX-H83/86L were gen-
erated by site-directed mutagenesis using the Quickchange kit (Strat-
agene) according to the manufacturer’s instructions.
 
Cell proliferation
 
For transfection, 5 
 
  
 
10
 
6
 
 cells were resuspended in 300 
 
 
 
l SFM with the
indicated amounts of expression vectors in combination with pEGFP-F (en-
coding farnesylated EGFP) and electroporated at 300 V and 450 
 
 
 
F.
Cells were allowed to recover in complete medium for 12 h. They were
then synchronized in G0, detached, and replated on FN-coated coverslips
under confluent conditions. After 4 h in SFM, cells were incubated with
growth factors and 10 
 
 
 
M BrdU (Boehringer) for 20 h. After fixation, they 
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were stained with anti-BrdU mAb (Boehringer) and TRITC-conjugated anti–
mouse IgGs (The Jackson Laboratory) to measure the percentage of GFP-
positive cells that had incorporated BrdU.
 
Biochemistry
 
PAK was immunoprecipitated from cell lysates with anti-Pak1 antibodies
(N-20; Santa Cruz Biotechnology, Inc.) and subjected to kinase as-
say with myelin basic protein as a substrate, as previously described
(Yablonski et al., 1998). The samples were also probed by immunoblot-
ting with the same antibody. GTP-Ras and GTP-Rac were pulled down
from 800 
 
 
 
g of total proteins using GST-Raf-RBD or GST-Pak67-150, re-
spectively, before immunoblotting with specific antibodies. For subcellular
fractionation, cells were homogenized with a Dounce homogenizer in
cold hypotonic buffer (10 mM Tris, pH 7.4, 1.5 mM MgCl
 
2
 
, 5 mM KCl,
1 mM EDTA, and protease inhibitors). After pelleting nuclei and intact
cells by centrifugation at 750 
 
g
 
 for 10 min, the supernatants were spun
at 10
 
5
 
 
 
g
 
 for 1 h. The resulting supernatants containing the cytosolic frac-
tion were kept aside, whereas the pellets were extracted with radioimmu-
noprecipitation buffer and briefly clarified at 10
 
5
 
 
 
g
 
 for 5 min to recover
the crude membrane fraction. An equal amount of proteins from the cyto-
solic or membrane fractions were analyzed by immunoblotting.
 
Optical imaging
 
Cells were transfected with a vector encoding GFP-Rac (pEGFP-Rac1) in
combination with constructs encoding various forms of PAK or Merlin. 12 h
after transfection, cells were starved for 24 h, detached, and replated
on FN-coated coverslips in SFM without growth factors. After an addi-
tional 4 h, 6.5- m polystylane Latex beads (Interfacial Dynamics Corp.)
were applied to the cells for 25 min at a beads to cell ratio of 40:1 (del
Pozo et al., 2002). Beads were washed with bicarbonate buffer, incu-
bated with 50  g/ml FN or 100  g/ml PL at RT for 1 h, and washed with
PBS. Cells were fixed in 4% PFA, permeabilized in 0.2% Triton X-100/
PBS, blocked in 2.5% BSA/goat serum, and incubated with primary anti-
bodies or rhodamine-conjugated phalloidin (0.1  g/ml, Sigma-Aldrich).
Samples were examined on an inverted microscope using 40 and 63 
1.5 oil immersion lenses (Axiovert 200M; Carl Zeiss MicroImaging, Inc.).
Confocal analysis was performed with an LSM510 instrument (Carl Zeiss
MicroImaging, Inc.).
RNA interference
The siRNA oligonucleotide TGGCCAACGAAGCACTGAT was designed
to target human but not mouse Merlin and was synthesized by the RNA in-
terference Facility of the Memorial Sloan-Kettering Cancer Center. Cells
were cultured in 6-well plates (Transwell Costar) until 40% confluent and
transfected with 1 ml of Opti-MEM (GIBCO BRL) containing 4  l of Oligo-
fectamine (Invitrogen) and 5  l of 20  M siRNA for 4 h. Cells were then
returned to complete SFM containing 20% FBS and growth factors for 24 h
and then deprived of growth factors for 24 h before the assays. For opti-
cal imaging, cells were first electroporated with HA-Rac (pXJ40-HA-Rac1)
and 3 h later detached and replated for transfection of siRNA. Cotransfec-
tion of fluorescent-labeled RNA oligo revealed that the efficiency of siRNA
transfection was  90%.
Online supplemental material
Fig. S1 shows that a large fraction of sparse HUVEC progress through
G1 and enter S phase after growth factor stimulation, whereas only a mi-
nor fraction of confluent cells progress through the cell cycle under other-
wise identical conditions. Confluent HUVEC undergo growth arrest as
they establish VE-cadherin–dependent junctions. Contact inhibition in
these cells is not due to segregation of RTKs from their cognate ligands or
inhibition of signaling to Ras and ERK. Fig. S2 shows that knockdown of
Merlin promotes formation of lamellipodia in sparse HUVEC. Online sup-
plemental material is available at http://www.jcb.org/cgi/content/full/
jcb.200503165/DC1.
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